Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study.

Dogra S, D S K, Budamakuntla L, Srinivas CR, Khopkar U, Gupta S, Shetty N, Pratap DV, Gopal MG, Rao TN, Garg V, Sumathy TK, Saraswat A, Bhat R, Kura M, Pandey N, Shah R, Sai Krishna K, Padmaja D, Manmohan G, M S R, Barve A, Montero E

Open source

DOI
10.1016/j.jaad.2015.03.040
Published
2015 Aug
Container
Journal of the American Academy of Dermatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaad.2015.03.040,
  title = {Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study.},
  author = {Dogra S and D S K and Budamakuntla L and Srinivas CR and Khopkar U and Gupta S and Shetty N and Pratap DV and Gopal MG and Rao TN and Garg V and Sumathy TK and Saraswat A and Bhat R and Kura M and Pandey N and Shah R and Sai Krishna K and Padmaja D and Manmohan G and M S R and Barve A and Montero E},
  year = {2015},
  journal = {Journal of the American Academy of Dermatology},
  doi = {10.1016/j.jaad.2015.03.040},
  url = {https://doi.org/10.1016/j.jaad.2015.03.040}
}

RIS

TY  - JOUR
TI  - Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study.
AU  - Dogra S
AU  - D S K
AU  - Budamakuntla L
AU  - Srinivas CR
AU  - Khopkar U
AU  - Gupta S
AU  - Shetty N
AU  - Pratap DV
AU  - Gopal MG
AU  - Rao TN
AU  - Garg V
AU  - Sumathy TK
AU  - Saraswat A
AU  - Bhat R
AU  - Kura M
AU  - Pandey N
AU  - Shah R
AU  - Sai Krishna K
AU  - Padmaja D
AU  - Manmohan G
AU  - M S R
AU  - Barve A
AU  - Montero E
PY  - 2015
JO  - Journal of the American Academy of Dermatology
DO  - 10.1016/j.jaad.2015.03.040
UR  - https://doi.org/10.1016/j.jaad.2015.03.040
ER  - 

APA

S, D., K, D. S., L, B., CR, S., U, K., S, G., N, S., DV, P., MG, G., TN, R., V, G., TK, S., A, S., R, B., M, K., N, P., R, S., K, S. K., D, P., G, M., R, M. S., A, B., & E, M. (2015). Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2015.03.040

Source records